nach oben

Indian Journal of Otolaryngology and Head & Neck Surgery

Erschienen in:

31.08.2020 | Original Article

Applicability of Dynamic Risk Stratification for Differentiated Thyroid Cancer (DTC) in a Resource Limited Setting

verfasst von: Karthik Munagala, S. Vijay Praveen, Keerthana Maadam, Shamit Chopra, Sanjay Kishve

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Sonderheft 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Dynamic risk stratification (DRS) in DTC has been considered necessary to deliver correct follow-up (FU) treatment, avoiding overtreatment of low risk/intermediate risk patients as well as inadequate treatment of high risk patients. However, it’s clinical applicability has been questioned in comparison with more conventional FU protocols. We aimed to know the predictive reliability of DRS in monitoring FU of DTC in a resource-constrained setting across various risk groups, especially when compared with clinical examination alone.

Unnikrishnan AG, Menon UV (2011) Thyroid disorders in India: an epidemiological perspective. Indian J Endocr Metab 15(Suppl S2):78–81CrossRef

Omry-Orbach G (2016) Risk stratification in differentiated thyroid cancer: an ongoing process. Rambam Maimonides Med J 7(1):e0003. https://doi.org/10.5041/rmmj.10230CrossRefPubMedPubMedCentral

Shah JP (2015) Thyroid carcinoma: epidemiology, histology, and diagnosis. Clin Adv Hematol Oncol 13(4 Suppl 4):3–6PubMedPubMedCentral

Cooper DS, Doherty GM et al (2009) American thyroid association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214. https://doi.org/10.1089/thy.2009.0110CrossRefPubMed

Vaisman F, Momesso D, Bulzico DA et al (2012) Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy. Clin Endocrinol (Oxf) 77:132–138. https://doi.org/10.1111/j.1365-2265.2012.04342.xCrossRefPubMed

Pacini F, Schlumberger M, Dralle H et al (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787–803. https://doi.org/10.1530/eje.1.02158CrossRefPubMed

Shaha AR (2004) Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope. 3:393–402CrossRef

Vaisman F, Tala H, Grewal R, Tuttle RM (2011) In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response. Thyroid 21:1317–1322CrossRefPubMed

Haugen BR, Alexander EK, Bible KC et al (2016) American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133. https://doi.org/10.1089/thy.2015.0020CrossRefPubMedPubMedCentral

10.

Momesso D, Vaisman F, Yang SP, Bulzico D, Corbo R, Vaisman M, Michael Tuttle R (2016) Dynamic risk stratification in differentiated thyroid cancer patients treated without radioactive iodine. J Clin Endocrinol Metab 101:jc20154290. https://doi.org/10.1210/jc.2015-4290CrossRef

11.

Amoako-Tuffour Y, Graham ME, Bullock M et al (2017) Papillary thyroid cancer recurrence 43 years following total thyroidectomy and radioactive iodine ablation: a case report. Thyroid Res 10:8. https://doi.org/10.1186/s13044-017-0043-4CrossRefPubMedPubMedCentral

12.

Cho BY, Choi HS, Park YJ et al (2013) Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. Thyroid 23(7):797–804CrossRefPubMedPubMedCentral

13.

Schlumberger M, Pacini F, Wiersinga WM et al (2004) Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice. Eur J Endocrinol 151:539–548CrossRefPubMed

14.

Jeon MJ, Kim WG, Park WR et al (2014) Modified dynamic risk stratification for predicting recurrence using the response to initial therapy in patients with differentiated thyroid carcinoma. Eur J Endocrinol 170:23–30CrossRefPubMed

15.

Kowalska A, Walczyk A, Pałyga I et al (2016) The delayed risk stratification system in the risk of differentiated thyroid cancer recurrence. PLoS ONE. 11(4):e0153242. https://doi.org/10.1371/journal.pone.0153242CrossRefPubMedPubMedCentral

16.

Morosán YJ, Parisi C, Urrutia MA, Rosmarin M, Schnitman M, Serrano L et al (2016) Dynamic prediction of the risk of recurrence in patients over 60 years of age with differentiated thyroid carcinoma. Arch Endocrinol Metab 60(4):348–354. https://doi.org/10.1590/2359-3997000000146CrossRefPubMed

17.

Hay ID (2006) Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma. J Surg Oncol 94:692–700CrossRefPubMed

18.

Durante C, Montesano T, Attard M et al (2012) Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement? J Clin Endocrinol Metab 97:2748–2753CrossRefPubMed

19.

Yoon JH, Han K, Kim EK, Moon HJ, Kwak JY (2017) Diagnosis and management of small thyroid nodules: a comparative study with six guidelines for thyroid nodules. Radiology 283(2):560–569. https://doi.org/10.1148/radiol.2016160641CrossRefPubMed

20.

Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH et al (2011) Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology 260:892–899CrossRefPubMed

21.

Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, Brokhin M, Omry G, Fagin JA, Shaha A (2010) Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American thyroid association staging system. Thyroid 20(12):1341–1349CrossRefPubMedPubMedCentral

22.

Tuttle RM (2008) Risk-adapted management of thyroid cancer. Endocr Pract 14:764–774. https://doi.org/10.4158/EP.14.6.764CrossRefPubMed

23.

Tuttle RM, Leboeuf R, Shaha AR (2008) Medical management of thyroid cancer: a risk adapted approach. J Surg Oncol 97:712–716. https://doi.org/10.1002/jso.21010CrossRefPubMed

24.

Castagna MG, Maino F, Cipri C et al (2011) Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome productivity in differentiated thyroid cancer patients. Eur J Endocrinol 165:441–446. https://doi.org/10.1530/EJE-11-0466CrossRefPubMed

25.

Hong CM, Lee WK, Jeong SY, Lee SW, Ahn BC, Lee J (2014) Superiority of delayed risk stratification in differentiated thyroid cancer after total thyroidectomy and radioactive iodine ablation. Nucl Med Commun 35:1119–1126. https://doi.org/10.1097/MNM.0000000000000183CrossRefPubMed

26.

Bal C, Ballal S, Soundararajan R, Chopra S, Garg A (2015) Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment. Cancer Med 4(7):1031–1038CrossRefPubMedPubMedCentral

Titel: Applicability of Dynamic Risk Stratification for Differentiated Thyroid Cancer (DTC) in a Resource Limited Setting
verfasst von: Karthik Munagala
S. Vijay Praveen
Keerthana Maadam
Shamit Chopra
Sanjay Kishve
Publikationsdatum: 31.08.2020
Verlag: Springer India
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe Sonderheft 2/2022
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI: https://doi.org/10.1007/s12070-020-02069-4

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Applicability of Dynamic Risk Stratification for Differentiated Thyroid Cancer (DTC) in a Resource Limited Setting

Abstract

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Update HNO

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 2/2022

Modified CT Scan Scoring System for Evaluating Symptom Severity of Chronic Rhinosinusitis

Cut Neck, Department of E.N.T in a Tertiary Centre: How We Approach

Jugular Vein Phlebectasia (IJP): Surgically Manageable But Ignored Entity

Tele-Otolaryngology at a Tertiary Care Center in North India During COVID-19 Pandemic Lockdown: A Validated Patient Feedback Questionnaire Based Study

A covid-19 Patient with Cavernous Sinus Thrombosis Post Dental Extraction a Diagnostic Dilemma

Outcome of Submucosal Inferior Turbinoplasty in Perennial Allergic Rhinitis

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Update HNO